Works matching DE "RIFAXIMIN"

Results: 146

Go with your gut: targeting the microbiome for treatment of irritable bowel syndrome.

Published in:

Drugs & Therapy Perspectives, 2023, v. 39, n. 11, p. 373, doi. 10.1007/s40267-023-01027-8

By:

Fung, Simon

Publication type:

Article

Additional L-Carnitine Reduced the Risk of Hospitalization in Patients with Overt Hepatic Encephalopathy on Rifaximin.

Published in:

Digestive Diseases, 2022, v. 40, n. 3, p. 313, doi. 10.1159/000518067

By:

Kubota, Kousuke;
Uojima, Haruki;
Shao, Xue;
Iwasaki, Shuichiro;
Hidaka, Hisashi;
Wada, Naohisa;
Nakazawa, Takahide;
Shibuya, Akitaka;
Kako, Makoto;
Koizumi, Wasaburo

Publication type:

Article

The Liver Meeting 2024: Bausch Health Presents Phase 3 Study Design for Investigational Rifaximin Formulation to Delay OHE.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

Monotherapy with Rifaximin vs Lactulose More Effective for Reducing Recurrence of Overt Hepatic Encephalopathy: New Post Hoc Analysis.

Published in:

Patient Care (Online), 2024, p. 3

By:

Halsey, Grace

Publication type:

Article

Diverticular Disease and Rifaximin: An Evidence-Based Review.

Published in:

Antibiotics (2079-6382), 2023, v. 12, n. 3, p. 443, doi. 10.3390/antibiotics12030443

By:

Piccin, Anna;
Gulotta, Marco;
di Bella, Stefano;
Martingano, Paola;
Crocè, Lory Saveria;
Giuffrè, Mauro

Publication type:

Article

Synthetic Imidazopyridine-Based Derivatives as Potential Inhibitors against Multi-Drug Resistant Bacterial Infections: A Review.

Published in:

Antibiotics (2079-6382), 2022, v. 11, n. 12, p. 1680, doi. 10.3390/antibiotics11121680

By:

Sanapalli, Bharat Kumar Reddy;
Ashames, Akram;
Sigalapalli, Dilep Kumar;
Shaik, Afzal B.;
Bhandare, Richie R.;
Yele, Vidyasrilekha

Publication type:

Article

NiFe2O4/GO Nanocomposite as an Effective Adsorbent for Modelling Removal of Rifaximin from Pharmaceutical Wastewater Using Box–Behnken Response Surface Methodology.

Published in:

Russian Journal of General Chemistry, 2023, v. 93, p. S934, doi. 10.1134/S1070363223170103

By:

Malmir, M.;
Shemirani, F.

Publication type:

Article

利福昔明在肝硬化相关并发症中的应用.

Published in:

Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2018, v. 34, n. 7, p. 1551, doi. 10.3969/j.issn.1001-5256.2018.07.040

By:

吕新月;
李磊

Publication type:

Article

Volatile cinnamaldehyde induces systemic salt tolerance in the roots of rice (Oryza sativa).

Published in:

Physiologia Plantarum, 2023, v. 175, n. 3, p. 1, doi. 10.1111/ppl.13938

By:

Huang, Chung‐Chih;
Lee, Yun‐Ting;
Ly, Thach‐Thao;
Wang, Chong‐Yue;
Chang, Yao‐Tsung;
Hou, Ping‐Fu;
Liu, Zin‐Huang;
Huang, Hao‐Jen

Publication type:

Article

Mean Blood Ammonia Level After Treatment With Rifaximin Versus Neomycin In Chronic Liver Disease Patients Presenting With Hepatic Encephalopathy.

Published in:

Annals of King Edward Medical University, 2019, v. 25, n. 1, p. 1

By:

Mumtaz, Sami Ullah;
Iqtadar, Somia;
Niaz, Zafar;
Komal, Tayyeba;
Abaidullah, Sajid

Publication type:

Article

Preparation of S-Scheme g-C 3 N 4 /ZnO Heterojunction Composite for Highly Efficient Photocatalytic Destruction of Refractory Organic Pollutant.

Published in:

Catalysts (2073-4344), 2023, v. 13, n. 3, p. 485, doi. 10.3390/catal13030485

By:

Sert, Buse;
Bilici, Zeynep;
Ocakoglu, Kasim;
Dizge, Nadir;
Rad, Tannaz Sadeghi;
Khataee, Alireza

Publication type:

Article

Effect of Trimebutine and Rifaximin on Breath Hydrogen and Methane by Glucose Breath Test in Patients With Functional Bloating: A Randomized Double-blind Clinical Trial.

Published in:

Journal of Neurogastroenterology & Motility, 2024, v. 30, n. 2, p. 220, doi. 10.5056/jnm23029

By:

Ik Hyun Jo;
Chang-Nyol Paik;
Ji Min Lee;
Do Seon Song;
Yeon-Ji Kim

Publication type:

Article

Distinct Effects of Non-absorbed Agents Rifaximin and Berberine on the Microbiota-Gut-Brain Axis in Dysbiosis-induced Visceral Hypersensitivity in Rats.

Published in:

Journal of Neurogastroenterology & Motility, 2023, v. 29, n. 4, p. 520, doi. 10.5056/jnm22182

By:

Jindong Zhang;
Cunzheng Zhang;
Tao Zhang;
Lu Zhang;
Liping Duan

Publication type:

Article

Rifaximin Improves Visceral Hyperalgesia via TRPV1 by Modulating Intestinal Flora in the Water Avoidance Stressed Rat.

Published in:

Gastroenterology Research & Practice, 2020, p. 1, doi. 10.1155/2020/4078681

By:

Yang, Chang-qing;
Guo, Xiao-shu;
Ji-Li;
Wei, Zi-bai;
Zhao, Li;
Zhao, Gan-ting;
Sheng, Shu-ting

Publication type:

Article

Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients.

Published in:

International Journal of Molecular Sciences, 2023, v. 24, n. 19, p. 14727, doi. 10.3390/ijms241914727

By:

Fiorillo, Alessandra;
Gallego, Juan José;
Casanova-Ferrer, Franc;
Urios, Amparo;
Ballester, María-Pilar;
San Miguel, Teresa;
Megías, Javier;
Kosenko, Elena;
Tosca, Joan;
Rios, Maria-Pilar;
Escudero-García, Desamparados;
Montoliu, Carmina

Publication type:

Article

Low-Dose Rifabutin Increases Cytotoxicity in Antimitotic-Drug-Treated Resistant Cancer Cells by Exhibiting Strong P-gp-Inhibitory Activity.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 13, p. 7383, doi. 10.3390/ijms23137383

By:

Lee, Ji Sun;
Oh, Yunmoon;
Kim, Hyung Sik;
Yoon, Sungpil

Publication type:

Article

Mitochondrial Side Effects of Surgical Prophylactic Antibiotics Ceftriaxone and Rifaximin Lead to Bowel Mucosal Damage.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 9, p. 5064, doi. 10.3390/ijms23095064

By:

Baráth, Bálint;
Jász, Dávid K.;
Horváth, Tamara;
Baráth, Bence;
Maróti, Gergely;
Strifler, Gerda;
Varga, Gabriella;
Sándor, Lilla;
Perényi, Domonkos;
Tallósy, Szabolcs;
Donka, Tibor;
Jávor, Péter;
Boros, Mihály;
Hartmann, Petra

Publication type:

Article

Preventive and therapeutic effects of rifaximin on hepatic encephalopathy with differential application dosages and strategies: a network meta-analysis.

Published in:

BMC Gastroenterology, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12876-024-03184-0

By:

Fang, Guihua;
Liu, Shuna;
Liu, Bin

Publication type:

Article

Adherence to rifaximin initiation and prescribing within King's College Hospital and transfer of prescribing to primary care.

Published in:

2023

By:

Monk, G;
Shah, S

Publication type:

Abstract

Gastrointestinal Involvement in Systemic Sclerosis - Review of 250 Patients' Clinical, Radiological and Serological Profile - A Retrospective Study.

Published in:

2024

By:

Jacob, Manna;
Mathew, Ashish;
Nithin, Koshy;
Goel, Ruchika;
Mathew, John

Publication type:

Abstract

A Review of Pharmacologic and Non-Pharmacologic Therapies in the Management of Irritable Bowel Syndrome: Current Recommendations and Evidence.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 22, p. 6948, doi. 10.3390/jcm13226948

By:

Papale, Anthony J.;
Flattau, Robert;
Vithlani, Nandan;
Mahajan, Deepti;
Nadella, Sandeep

Publication type:

Article

The Management of Hepatic Encephalopathy from Ward to Domiciliary Care: Current Evidence and Gray Areas.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 1, p. 166, doi. 10.3390/jcm13010166

By:

Bellafante, Daniele;
Gioia, Stefania;
Faccioli, Jessica;
Riggio, Oliviero;
Ridola, Lorenzo;
Nardelli, Silvia

Publication type:

Article

Post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) Hepatic Encephalopathy—A Review of the Past Decade's Literature Focusing on Incidence, Risk Factors, and Prophylaxis.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 1, p. 14, doi. 10.3390/jcm13010014

By:

Friis, Karina Holm;
Thomsen, Karen Louise;
Laleman, Wim;
Montagnese, Sara;
Vilstrup, Hendrik;
Lauridsen, Mette Munk

Publication type:

Article

Rifaximin Reduces Risk of All-Cause Hospitalization in Cirrhotic Liver Transplant Candidates with Hepatic Encephalopathy.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 21, p. 6871, doi. 10.3390/jcm12216871

By:

Parisse, Simona;
Lai, Quirino;
Martini, Francesca;
Martini, Alice;
Ferri, Flaminia;
Mischitelli, Monica;
Melandro, Fabio;
Mennini, Gianluca;
Rossi, Massimo;
Alvaro, Domenico;
Ginanni Corradini, Stefano

Publication type:

Article

Rifaximin Use, Adherence and Persistence in Patients with Hepatic Encephalopathy: A Real-World Study in the South of Italy.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4515, doi. 10.3390/jcm12134515

By:

Pandico, Fulvio;
Citarella, Anna;
Cammarota, Simona;
Bernardi, Francesca Futura;
Claar, Ernesto;
Coppola, Carmine;
Cozzolino, Marianna;
De Rosa, Federica;
Di Gennaro, Massimo;
Fogliasecca, Marianna;
Giordana, Roberta;
Pacella, Daniela;
Russo, Alessandro;
Salerno, Vito;
Scafa, Luca;
Trama, Ugo

Publication type:

Article

Severe Ulcerative Colitis Complicated by Malakoplakia Resulting in Proctocolectomy.

Published in:

ACG Case Reports Journal, 2024, v. 11, n. 1, p. 1, doi. 10.14309/crj.0000000000001257

By:

Alphonsus, Lotus;
De Silva, Theshani A.;
Driman, David;
Jairath, Vipul

Publication type:

Article

Role of non-absorbable oral antibiotics in bowel preparation for intracavitary brachytherapy: effects of rifaximin on rectal dosimetric parameters during vaginal cuff brachytherapy.

Published in:

Journal of Contemporary Brachytherapy, 2021, v. 13, n. 4, p. 426, doi. 10.5114/jcb.2021.108597

By:

Razmjoo, Sasan;
Bagheri, Ali;
Shahbazian, Hodjatollah;
Hosseini, Seyed-Mohammad;
Ebrahimian-Tabrizi, Faezeh

Publication type:

Article

Irritable bowel syndrome in adolescents.

Published in:

Journal of Alternative Medicine Research, 2023, v. 15, n. 4, p. 407

By:

Schmalz, Michael;
Gomes, Theotonius J.

Publication type:

Article

A comparative study to determine the short-term mortality and clinical improvement in hepatic encephalopathy using either rifaximin and or lactulose.

Published in:

Asian Journal of Medical Sciences, 2021, v. 12, n. 3, p. 46, doi. 10.3126/ajms.v12i3.32808

By:

Biswas, Uttam;
Pal, Shyamal Kanti;
Chaudhuri, Pallabi Ray;
Roychowdhury, Debanjan;
Dhar, Abhranil;
Roy, Anirudhdha

Publication type:

Article

Eco-Friendly Pharmaceutical Analysis of Rifaximin in Tablets by HPLC-MS and Microbiological Turbidimetry.

Published in:

Journal of Chromatographic Science, 2021, v. 59, n. 7, p. 597, doi. 10.1093/chromsci/bmab044

By:

Kogawa, Ana Carolina;
Mendonça, Jacqueline Nakau;
Lopes, Norberto Peporine;
Salgado, Hérida Regina Nunes

Publication type:

Article

Rifaximin modulates TRH and TRH-like peptide expression throughout the brain and peripheral tissues of male rats.

Published in:

2022

By:

Pekary, Albert Eugene;
Sattin, Albert

Publication type:

journal article

Modulation of the microbiota across different intestinal segments by Rifaximin in PI-IBS mice.

Published in:

BMC Microbiology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12866-023-02772-6

By:

Zhang, Shengyan;
Hong, Gaichao;
Li, Gangping;
Qian, Wei;
Jin, Yu;
Hou, Xiaohua

Publication type:

Article

Corrigendum to Prophylactic antibiotics in patients with alcohol‐associated hepatitis receiving steroids: A systematic review and meta‐analysis.

Published in:: 2024
Publication type:: Correction Notice

Rifaximin may induce rifampicin resistance in coagulase‐negative staphylococci.

Published in:

Liver International, 2023, v. 43, n. 9, p. 2039, doi. 10.1111/liv.15667

By:

Schulte, Lina M.;
Nattermann, Jacob;
Strassburg, Christian P.;
Lutz, Philipp

Publication type:

Article

Amalgam of ternary solid dispersion and P-gp efflux inhibition in development of colon-targeted tablets of rifaximin.

Published in:

Journal of Reports in Pharmaceutical Sciences, 2022, v. 11, n. 2, p. 222, doi. 10.4103/jrptps.JRPTPS_21_22

By:

Lalan, Manisha;
Shah, Pranav;
Kadam, Ruchita;
Patel, Himan

Publication type:

Article

An Effectiveness of Ayurveda Management in Crohn's Disease.

Published in:

Journal of Integrated Health Sciences, 2024, v. 12, n. 1, p. 80, doi. 10.4103/jihs.jihs_13_24

By:

Varsakiya, Jitendrakumar Nathabhai;
Agarwal, Bhawana;
Kathad, Divyarani;
Ravi, Arun Kumar;
Dwivedi, Shiv Prasad

Publication type:

Article

On the Analytic Characteristics of Commercial Acetaminophen Assays in the United States .

Published in:

Journal of Applied Laboratory Medicine, 2022, v. 7, n. 6, p. 1311, doi. 10.1093/jalm/jfac059

By:

Ali, Khameinei;
Chiang, William;
Wang, Josh Jiaxing

Publication type:

Article

FORMULATION AND CHARACTERIZATION OF RIFAXIMIN COLON TARGETING NANOSPONGES.

Published in:

Biochemical & Cellular Archives, 2024, p. 3569, doi. 10.51470/bca.2024.24.1-S.3569

By:

Kanaujiya, Ashish Kumar;
Shah, Sunil Kumar;
Dubey, B. K.;
Basedia, Deepak Kumar

Publication type:

Article

Ziziphus spina-christi Leaf-Derived Carbon Dots as a Fluorescence Nanosensor to Evaluate Rifaximin Antibacterial via Inner Filter Effect: Greenness and Whiteness Studies.

Published in:

Chemosensors, 2023, v. 11, n. 5, p. 275, doi. 10.3390/chemosensors11050275

By:

Hamd, Mohamed A. El;
Albalawi, Marzough Aziz;
Gomaa, Hassanien;
Mohammad, Bassam Shaaban;
Abdul-Kareem, Rady F.;
Obaydo, Reem H.;
Alsaggaf, Wejdan T.;
Saleh, Safaa F.;
Alossaimi, Manal A.;
Abdel-Lateef, Mohamed A.

Publication type:

Article

Rifaximin Improves Spatial Learning and Memory Impairment in Rats with Liver Damage-Associated Neuroinflammation.

Published in:

Biomedicines, 2022, v. 10, n. 6, p. 1263, doi. 10.3390/biomedicines10061263

By:

Leone, Paola;
Mincheva, Gergana;
Balzano, Tiziano;
Malaguarnera, Michele;
Felipo, Vicente;
Llansola, Marta

Publication type:

Article

Rifaximin prophylaxis in MASLD‑hepatocellular carcinoma: Lessons from a negative animal model.

Published in:

Biomedical Reports, 2025, v. 22, n. 1, p. N.PAG, doi. 10.3892/br.2024.1882

By:

Longo, Larisse;
Guerreiro, Gabriel Tayguara Silveira;
Behrens, Luiza;
Pereira, Matheus Henrique Mariano;
Pinzon, Carlos Eduardo;
Cerski, Carlos Thadeu Schmidt;
Uribe-Cruz, Carolina;
Álvares-da-Silva, Mário Reis

Publication type:

Article

Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study).

Published in:

Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1121435

By:

Huaizhu Guo;
Siqi Lu;
Jindong Zhang;
Chen Chen;
Yanlin Du;
Kun Wang;
Liping Duan

Publication type:

Article

A PK/PD model for the evaluation of clinical rifaximin dosage for the treatment of dairy cow mastitis induced by Escherichia coli.

Published in:

BMC Veterinary Research, 2023, v. 19, n. 1, p. 1, doi. 10.1186/s12917-022-03564-2

By:

Wang, Honglei;
Chen, Chen;
Liu, Chunshuang;
Chen, Xiaojie;
Zhang, Jingju;
Wang, Yufeng;
Han, Mingyue;
Liu, Yiming;
Li, Xiubo

Publication type:

Article

Comparison of Safety and Efficacy of Neomycin versus Rifaximin in Chronic Recurrent Hepatic Encephalopathy.

Published in:

QJM: An International Journal of Medicine, 2024, v. 117, p. ii156, doi. 10.1093/qjmed/hcae175.363

By:

Ahmed Alaasar, Asmaa Ahmed Ali;
Monis, Ahmed Ali;
Riad, George Safwat;
Talkhan, Mohamed Gamal

Publication type:

Article

A Prospective Multimodal Education Intervention for Providers Does Not Increase Hepatic Encephalopathy Treatment Rates.

Published in:

Digestive Diseases & Sciences, 2024, v. 69, n. 6, p. 1996, doi. 10.1007/s10620-024-08445-2

By:

Twohig, Patrick A.;
Peeraphatdit, Thoetchai Bee;
Samson, Kaeli;
Schissel, Makayla;
Smith, Lynette;
Ashford, Allison;
Freese, Laura;
McCashland, Timothy

Publication type:

Article

Italian guidelines for the management of irritable bowel syndrome in children and adolescents: Joint Consensus from the Italian Societies of: Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP), Pediatrics (SIP), Gastroenterology and Endoscopy (SIGE) and Neurogastroenterology and Motility (SINGEM)

Published in:

Italian Journal of Pediatrics, 2024, v. 50, n. 1, p. 1, doi. 10.1186/s13052-024-01607-y

By:

Di Nardo, Giovanni;
Barbara, Giovanni;
Borrelli, Osvaldo;
Cremon, Cesare;
Giorgio, Valentina;
Greco, Luigi;
La Pietra, Michele;
Marasco, Giovanni;
Pensabene, Licia;
Piccirillo, Marisa;
Romano, Claudio;
Salvatore, Silvia;
Saviano, Michele;
Stanghellini, Vincenzo;
Strisciuglio, Caterina;
Tambucci, Renato;
Turco, Rossella;
Zenzeri, Letizia;
Staiano, Annamaria

Publication type:

Article

Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat.

Published in:

Journal of Neuroinflammation, 2021, v. 18, n. 1, p. 1, doi. 10.1186/s12974-021-02303-y

By:

Li, Haonan;
Xiang, Yujiao;
Zhu, Zemeng;
Wang, Wei;
Jiang, Zhijun;
Zhao, Mingyue;
Cheng, Shuyue;
Pan, Fang;
Liu, Dexiang;
Ho, Roger C. M.;
Ho, Cyrus S. H.

Publication type:

Article

Clinical Transplant Kidney Function Loss Due to Small Intestinal Bacterial Overgrowth.

Published in:

Indian Journal of Nephrology, 2024, v. 34, n. 5, p. 526, doi. 10.25259/ijn_535_23

By:

Kise, Tomoo;
Uehara, Masatsugu

Publication type:

Article

利福昔明联合枯草杆菌二联活菌治疗小肠细菌过度生长的研究.

Published in:

Journal of Practical Medicine / Shiyong Yixue Zazhi, 2023, v. 39, n. 14, p. 1815, doi. 10.3969/j.issn.1006-5725.2023.14.015

By:

于兰;
闫志辉;
罗哲;
郑岩;
崔立红

Publication type:

Article

Rifaximin short-term useful for irritable bowel syndrome: Long-term added value is unclear.

Published in:

Geneesmiddelenbulletin, 2024, v. 58, n. 9, p. 17

By:

van den Bogert, Sander

Publication type:

Article